Evoq Remedies Limited (BOM:543500)
India · Delayed Price · Currency is INR 3.110
-0.100 (-3.12%)
At close: Jun 3, 2026
Evoq Remedies Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 255.07 | 117.57 | 40.53 | 203.9 | 167.83 |
Other Revenue | 12.5 | 24.15 | 22.57 | 60.23 | - |
| 267.57 | 141.71 | 63.09 | 264.13 | 167.83 | |
Revenue Growth (YoY) | 88.81% | 124.62% | -76.11% | 57.38% | 67.42% |
Cost of Revenue | 254.75 | 130.83 | 15.66 | 193.28 | 138.05 |
Gross Profit | 12.82 | 10.89 | 47.43 | 70.85 | 29.78 |
Selling, General & Admin | 0.69 | 0.68 | 4.52 | 4.76 | 4.49 |
Other Operating Expenses | 14.13 | 8.44 | 36.73 | 43.19 | 10.66 |
Operating Expenses | 15.33 | 9.61 | 41.32 | 47.99 | 15.15 |
Operating Income | -2.51 | 1.28 | 6.12 | 22.86 | 14.63 |
Other Non Operating Income (Expenses) | - | - | -0 | -0.01 | -0.05 |
Pretax Income | -2.51 | 1.28 | 6.11 | 22.85 | 14.58 |
Income Tax Expense | -0.11 | 0.4 | 1.59 | 6.65 | 3.67 |
Net Income | -2.4 | 0.88 | 4.52 | 16.19 | 10.91 |
Net Income to Common | -2.4 | 0.88 | 4.52 | 16.19 | 10.91 |
Net Income Growth | - | -80.50% | -72.06% | 48.38% | 52.53% |
Shares Outstanding (Basic) | 24 | 25 | 14 | 14 | 10 |
Shares Outstanding (Diluted) | 24 | 25 | 14 | 14 | 10 |
Shares Change (YoY) | -3.65% | 83.09% | - | 35.84% | 900.56% |
EPS (Basic) | -0.10 | 0.04 | 0.33 | 1.19 | 1.09 |
EPS (Diluted) | -0.10 | 0.04 | 0.33 | 1.19 | 1.09 |
EPS Growth | - | -89.27% | -72.27% | 9.17% | -84.75% |
Free Cash Flow | -2.82 | -148.81 | 53.08 | -43.59 | -276.38 |
Free Cash Flow Per Share | -0.12 | -5.98 | 3.90 | -3.21 | -27.61 |
Gross Margin | 4.79% | 7.68% | 75.19% | 26.82% | 17.74% |
Operating Margin | -0.94% | 0.91% | 9.69% | 8.65% | 8.72% |
Profit Margin | -0.90% | 0.62% | 7.17% | 6.13% | 6.50% |
Free Cash Flow Margin | -1.05% | -105.01% | 84.13% | -16.50% | -164.68% |
EBITDA | -2 | 1.77 | 6.19 | 22.9 | - |
EBITDA Margin | -0.75% | 1.25% | 9.81% | 8.67% | - |
D&A For EBITDA | 0.51 | 0.49 | 0.07 | 0.04 | - |
EBIT | -2.51 | 1.28 | 6.12 | 22.86 | 14.63 |
EBIT Margin | -0.94% | 0.91% | 9.69% | 8.65% | 8.72% |
Effective Tax Rate | - | 31.20% | 26.01% | 29.12% | 25.17% |
Revenue as Reported | 267.57 | 141.71 | 63.09 | 264.13 | 167.83 |
Advertising Expenses | - | - | 3.74 | 2.58 | 2.62 |